WAY OF DIAGNOSTICS OF DEGREE OF DISTURBANCE OF CARDIOVASCULAR SYSTEM FUNCTION AT NEWBORNS FROM GROUP WITH HIGH PERINATAL RISK Russian patent published in 2009 - IPC G01N33/68 

FIELD: medicine.

SUBSTANCE: invention concerns medicine area, namely to pediatrics, and can be used for diagnostics of degree of disturbance of cardiovascular system function at newborns from groups of perinatal risk. Essence of the way: peptide fraction of "N-trailer fragment (or a N-terminal fragment) of the precursor of cerebral sodium-uretic peptide" - level NT-pro-BNP is defined at newborns in the first days of a life in blood serum. Detection in blood serum of NT-pro-BNP level testifies: to 440 fmol/ml - there is no disturbance of function, from 441 to 603 fmol/ml - adaptic dysfunction, from 604 to 1636 fmol/ml - easy degree from 1636 to 2465 fmol/ml - intermediate degree, more than 2465 fmol/ml - serious degree the obtained data allow to make the clinical diagnosis with the greatest accuracy in as much as possible early terms. Application of a way allows prescribing pathogenetically caused therapy.

EFFECT: simple and effective way of differential diagnostics of organic and functional damages of cardiovascular system at newborns from group of perinatal risk.

5 ex